Flavones from Heavenly Blue as modulators of Alzheimer’s amyloid-beta peptide (Aβ) production
- 30 November 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in Medicinal Chemistry Research
- Vol. 27 (3), 768-776
- https://doi.org/10.1007/s00044-017-2100-x
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Development Fund (STDF), Egypt (Grant No 260)
This publication has 30 references indexed in Scilit:
- Phytochemical composition, protective and therapeutic effect on gastric ulcer and α-amylase inhibitory activity of Achillea biebersteinii Afan.Archives of Pharmacal Research, 2015
- The effects of C-glycosylation of luteolin on its antioxidant, anti-Alzheimer’s disease, anti-diabetic, and anti-inflammatory activitiesArchives of Pharmacal Research, 2014
- In vitro anti-nitrosative, antioxidant, and cytotoxicity activities of plant flavonoids: a comparative studyMedicinal Chemistry Research, 2014
- Ipomoea obscura ameliorates cyclophosphamide-induced toxicity by modulating the immune system and levels of proinflammatory cytokine and GSHCanadian Journal of Physiology and Pharmacology, 2010
- Alzheimer's diseaseThe Lancet, 2006
- Identification and Characterization of Presenilin-independent Notch SignalingOnline Journal of Public Health Informatics, 2002
- Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrierNeuropharmacology, 2001
- Quercetin Glucosides Interact With the Intestinal Glucose Transport PathwayFree Radical Biology & Medicine, 1998
- Etodolac selectively inhibits human prostaglandin G/H synthase 2 (PGHS-2) versus human PGHS-1European Journal of Pharmacology, 1995
- Animal models for studying transport across the blood-brain barrierJournal of Neuroscience Methods, 1995